Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

0.1215 -0.0105 (-7.95%)
Streaming Delayed Price Updated: 2:46 PM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,049,582
Open 0.1299
Bid (Size) 0.1215 (51)
Ask (Size) 0.1236 (1)
Prev. Close 0.1320
Today's Range 0.1177 - 0.1382
52wk Range 0.1255 - 0.8700
Shares Outstanding 40,710,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top stock movements in today's session.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Tuesday's session: top gainers and losers
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill

Performance

YTD
-71.0%
-71.0%
1 Month
-63.2%
-63.2%
3 Month
-67.3%
-67.3%
6 Month
-74.0%
-74.0%
1 Year
-82.8%
-82.8%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Crude Oil Moves Lower; Citigroup Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Nasdaq Surges 100 Points; Bank of America Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
From Spruce Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder
Via Benzinga
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From Spruce Biosciences, Inc.
Via Business Wire
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
Via AB Newswire
Spruce Biosciences Recognized as a Bay Area Best Place to Work
From Spruce Biosciences, Inc.
Via Business Wire
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
Via Benzinga
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
From Spruce Biosciences, Inc.
Via Business Wire
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace

Frequently Asked Questions

Is Spruce Biosciences, Inc. - Common Stock publicly traded?
Yes, Spruce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Spruce Biosciences, Inc. - Common Stock trade on?
Spruce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Spruce Biosciences, Inc. - Common Stock?
The ticker symbol for Spruce Biosciences, Inc. - Common Stock is SPRB on the Nasdaq Stock Market
What is the current price of Spruce Biosciences, Inc. - Common Stock?
The current price of Spruce Biosciences, Inc. - Common Stock is 0.1215
When was Spruce Biosciences, Inc. - Common Stock last traded?
The last trade of Spruce Biosciences, Inc. - Common Stock was at 04/16/25 02:46 PM ET
What is the market capitalization of Spruce Biosciences, Inc. - Common Stock?
The market capitalization of Spruce Biosciences, Inc. - Common Stock is 4.95M
How many shares of Spruce Biosciences, Inc. - Common Stock are outstanding?
Spruce Biosciences, Inc. - Common Stock has 5M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.